• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吉兰-巴雷综合征患者IgG抗体引起的神经肌肉阻滞:一项膜片钳宏观研究

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.

作者信息

Buchwald B, Toyka K V, Zielasek J, Weishaupt A, Schweiger S, Dudel J

机构信息

Neurologische Klinik der Bayerischen Julius-Maximilians-Universität, Würzburg, Germany.

出版信息

Ann Neurol. 1998 Dec;44(6):913-22. doi: 10.1002/ana.410440610.

DOI:10.1002/ana.410440610
PMID:9851436
Abstract

Guillain-Barré syndrome (GBS) is often associated with serum antibodies to glycoconjugates such as GM1 and GQ1b. The pathogenic role of these antibodies and other serum factors has not yet been clarified. We have investigated the effect of serum, plasma filtrate, and highly purified IgG and IgM from 10 patients with typical GBS on motor nerve terminals in the mouse hemidiaphragm. Quantal endplate currents were recorded by means of a perfused macro-patch-clamp electrode. The plasma filtrate of all GBS patients led to a 5- to 20-fold reduction of evoked quantal release within 7 to 15 minutes of continuous superfusion. In 4 patients, the amplitudes of single quanta were clearly reduced (by 10-66% of control values), indicating an additional postsynaptic action. Blocking effects could be reversed to a variable degree within 15 to 18 minutes after washout. Purified IgG was as effective as native serum, whereas a purified GBS IgM fraction did not block transmission. Sera from convalescent patients and IgG from healthy subjects were without blocking effect. The effects were complement independent and there was no link to the presence (in 6 patients) or absence (in 4 patients) of detectable antibodies to GM1 or GQ1b. In GBS, antibodies to an undetermined antigen depress the presynaptic transmitter release and, in some cases, the activation of postsynaptic channels. We suggest that weakness in the acute stage of GBS may be caused in part by circulating antibodies.

摘要

吉兰-巴雷综合征(GBS)常与针对糖缀合物(如GM1和GQ1b)的血清抗体相关。这些抗体及其他血清因子的致病作用尚未明确。我们研究了10例典型GBS患者的血清、血浆滤液以及高度纯化的IgG和IgM对小鼠半膈肌运动神经末梢的影响。通过灌注式宏观膜片钳电极记录量子化终板电流。所有GBS患者的血浆滤液在持续灌注7至15分钟内可使诱发的量子释放减少5至20倍。在4例患者中,单个量子的幅度明显降低(降至对照值的10% - 66%),表明存在额外的突触后作用。洗脱后15至18分钟内,阻断作用可不同程度地逆转。纯化的IgG与天然血清效果相同,而纯化的GBS IgM组分不阻断传递。恢复期患者的血清和健康受试者的IgG无阻断作用。这些作用不依赖补体,且与是否存在可检测到的抗GM1或GQ1b抗体(6例患者存在,4例患者不存在)无关。在GBS中,针对未确定抗原的抗体可抑制突触前递质释放,在某些情况下还可抑制突触后通道的激活。我们认为GBS急性期的肌无力可能部分由循环抗体引起。

相似文献

1
Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.吉兰-巴雷综合征患者IgG抗体引起的神经肌肉阻滞:一项膜片钳宏观研究
Ann Neurol. 1998 Dec;44(6):913-22. doi: 10.1002/ana.410440610.
2
Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.静脉注射免疫球蛋白可中和吉兰-巴雷综合征中的阻断抗体。
Ann Neurol. 2002 Jun;51(6):673-80. doi: 10.1002/ana.10205.
3
IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels.吉兰-巴雷综合征患者的IgG与烟碱型乙酰胆碱受体通道相互作用。
Muscle Nerve. 2003 Apr;27(4):435-41. doi: 10.1002/mus.10349.
4
Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.关于伴有IgG抗GalNAc-GD1a抗体的吉兰-巴雷综合征的神经生理学和免疫组织化学研究——对神经肌肉传递的影响
J Neurol Sci. 2004 Oct 15;225(1-2):91-8. doi: 10.1016/j.jns.2004.07.011.
5
Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome.IgG抗体在米勒-费雪综合征中的突触前和突触后联合作用
Neurology. 2001 Jan 9;56(1):67-74. doi: 10.1212/wnl.56.1.67.
6
Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals.米勒-费雪综合征免疫球蛋白G对小鼠运动神经末梢神经肌肉传递的突触前和突触后阻滞作用
Eur J Neurosci. 1998 Jan;10(1):281-90. doi: 10.1046/j.1460-9568.1998.00053.x.
7
Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.注射神经节苷脂后出现针对运动轴突的IgG抗体的急性轴索性吉兰-巴雷综合征。
Ann Neurol. 1995 Aug;38(2):218-24. doi: 10.1002/ana.410380214.
8
Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.免疫球蛋白通过抑制抗体结合,在运动神经末梢抑制抗GQ1b阳性血清的病理生理效应。
Brain. 2003 Oct;126(Pt 10):2220-34. doi: 10.1093/brain/awg235. Epub 2003 Jul 22.
9
Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.兰伯特-伊顿肌无力综合征患者免疫球蛋白G的突触前效应:静脉注射免疫球蛋白对其的中和作用。
Muscle Nerve. 2005 Apr;31(4):487-94. doi: 10.1002/mus.20269.
10
[Antiganglioside autoantibody profiles in Guillain-Barré syndrome].[吉兰-巴雷综合征中的抗神经节苷脂自身抗体谱]
Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):589-97.

引用本文的文献

1
Effects of IgG anti-GM1 monoclonal antibodies on neuromuscular transmission and calcium channel binding in rat neuromuscular junctions.IgG抗GM1单克隆抗体对大鼠神经肌肉接头处神经肌肉传递及钙通道结合的影响。
Exp Ther Med. 2015 Aug;10(2):535-540. doi: 10.3892/etm.2015.2575. Epub 2015 Jun 12.
2
[Guillain-Barré syndrome after exposure to influenza].暴露于流感后发生的吉兰-巴雷综合征
Nervenarzt. 2012 Jun;83(6):714-30. doi: 10.1007/s00115-012-3479-8.
3
Pathogenesis and treatment of immune-mediated neuropathies.免疫介导性神经病变的发病机制与治疗。
Ther Adv Neurol Disord. 2009 Jul;2(4):261-81. doi: 10.1177/1756285609104792.
4
An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome.抗聚糖抗体在吉兰-巴雷综合征中病理生物学作用的最新进展。
F1000 Biol Rep. 2010 Mar 25;2:21. doi: 10.3410/B2-21.
5
Tissue binding patterns and in vitro effects of Campylobacter jejuni DNA-binding protein from starved cells.饥饿细胞中弯曲杆菌 DNA 结合蛋白的组织结合模式和体外效应。
Neurochem Res. 2011 Jan;36(1):58-66. doi: 10.1007/s11064-010-0263-7. Epub 2010 Sep 19.
6
Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain-Barré syndrome?一过性免疫抑制:感染与吉兰-巴雷综合征非典型自身免疫之间的桥梁?
Clin Exp Immunol. 2010 Oct;162(1):32-40. doi: 10.1111/j.1365-2249.2010.04223.x.
7
Development of a novel therapy for Lipo-oligosaccharide-induced experimental neuritis: use of peptide glycomimics.新型脂寡糖诱导实验性神经炎治疗方法的研制:肽聚糖模拟物的应用。
J Neurochem. 2010 Apr;113(2):351-62. doi: 10.1111/j.1471-4159.2010.06627.x. Epub 2010 Feb 1.
8
Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.神经病变相关抗神经节苷脂抗体在神经肌肉接头处的病理生理作用。
J Physiol. 2009 Aug 15;587(Pt 16):3979-99. doi: 10.1113/jphysiol.2009.171702. Epub 2009 Jun 29.
9
Anti-ganglioside antibodies alter presynaptic release and calcium influx.抗神经节苷脂抗体可改变突触前释放及钙内流。
Neurobiol Dis. 2007 Oct;28(1):113-21. doi: 10.1016/j.nbd.2007.07.008. Epub 2007 Jul 14.
10
Airway management in neurological emergencies.神经科急症中的气道管理。
Neurocrit Care. 2004;1(4):405-14. doi: 10.1385/NCC:1:4:405.